SUCS portfolio includes
SUCS has plans in place to expand its current portfolio and also enter international markets. It has demonstrated strong performance in the European and with the backing of its owners, wishes to expand. It will do this by either developing its own products or in-licensing and distributing others. This model can be used in the Vietnam and overseas.
SUCS is also looking for partnership opportunities, where we may be able to share and distribute products, but also gain access to new territories for our portfolio. .
Product development & pipeline
In house development and partnership opportunities
Since it began, SUCS has invested heavily in product innovation and pipeline research. SUCS has a growing portfolio of products which it wishes to add to. It will do this by either developing its own products, or by working with partners to distribute and in-license products.
SUCS`s main focus is on ocular surface disease, unmet clinical needs and surgical opportunities. It has identified promising opportunities for innovation and new products.
SUCS will target important and fast-growing areas of medical need and is particularly interested in products for orphan indications, glaucoma, dry eye and cataract surgery. SUCS’s product pipeline is supported strongly by patents, orphan designations, licenses, know-how and trademarks.